Pfizer Profit Margin Trend from 2010 to 2020 
PFE  USA Stock  Trending 
Search Historical Trends
Pfizer Profit Margin 
Pfizer Quarterly Profit Margin
Pfizer Profit Margin Marginal Breakdown
Showing smoothed Profit Margin of Pfizer Inc with missing and latest data points interpolated. Measures the ratio between a company's Net Income Common Stock and Revenues.
View  Last Reported 31.17 %  10 Years Trend 

Profit Margin 
Timeline 
Pfizer Profit Margin Regression Statistics
Arithmetic Mean  23.62 
Geometric Mean  21.60 
Coefficient Of Variation  45.38 
Mean Deviation  8.66 
Median  20.79 
Standard Deviation  10.72 
Sample Variance  114.91 
Range  30.48 
RValue  0.33 
Mean Square Error  113.92 
RSquared  0.11 
Significance  0.32 
Slope  1.06 
Total Sum of Squares  1,149 
Pfizer Profit Margin Over Time
About Pfizer Financial Statement Charts
There are typically three primary documents that fall into the category of financial statements. These documents include Pfizer income statement, its balance sheet, and the statement of cash flows. Pfizer investors use historical funamental indicators, such as Pfizer's Profit Margin, to determine how well the company is positioned to perform in the future. Although Pfizer investors may use each financial statement separately, they are all related. The changes in Pfizer's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pfizer's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pfizer Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pfizer. Please read more on our technical analysis and fundamental analysis pages.
2017  2018  2019  2020 (projected)  
Receivables  8.22 B  8.03 B  8.72 B  10.38 B 
Inventories  7.58 B  7.51 B  8.28 B  7.42 B 
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze riskadjusted returns against different time horizons to find assetallocation targets 
All Next  Launch Module 
Currently Active Assets on Macroaxis
Please check the analysis of Pfizer Correlation with competitors. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies,
are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information
is derived directly from data published by
companies or submitted to governmental agencies which we believe are reliable, but are without our
independent verification. Therefore, we cannot assure you that the information is accurate or complete.
We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations.
Also, note that past performance is not necessarily indicative of future results. All investments carry risk,
and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee
that systems, indicators, or signals will result in profits or that they will not result in losses.
All investors are advised to fully understand all risks associated with any investing they choose to do.
Hypothetical or simulated performance is not indicative of future results.
We make no representations or warranties that any investor will, or is likely to, achieve profits
similar to those shown because hypothetical or simulated performance is not necessarily indicative
of future results. For more information please visit our
terms and condition page